ArticleOpen forum infectious diseases2025

Assessment of Failures of Long-acting Cabotegravir and Rilpivirine in a Real-world Treatment Setting.

Nicholas Yared et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.